TrialRespiratory research2015

Dose-finding evaluation of once-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with asthma: results of a parallel-group study and a crossover study.

Paul M O'Byrne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.